The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance
E Zucca, F Bertoni - Blood, The Journal of the American Society …, 2016 - ashpublications.org
Extranodal marginal zone (MZ) B-cell lymphomas of the mucosa-associated lymphoid tissue
(MALT) arise from lymphoid populations that are induced by chronic inflammation in …
(MALT) arise from lymphoid populations that are induced by chronic inflammation in …
Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)
M Raderer, B Kiesewetter… - CA: a cancer journal for …, 2016 - Wiley Online Library
Answer questions and earn CME/CNE Extranodal marginal zone lymphoma of the mucosa‐
associated lymphoid tissue (MALT lymphoma) accounts for 7% to 8% of newly diagnosed …
associated lymphoid tissue (MALT lymphoma) accounts for 7% to 8% of newly diagnosed …
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up✰
E Zucca, L Arcaini, C Buske, PW Johnson… - Annals of …, 2020 - annalsofoncology.org
In the last update of the World Health Organization (WHO) classification, the marginal zone
B-cell lymphomas (MZLs) comprise extranodal MZL (EMZL) of mucosa-associated lymphoid …
B-cell lymphomas (MZLs) comprise extranodal MZL (EMZL) of mucosa-associated lymphoid …
Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma
A Noy, S De Vos, C Thieblemont… - Blood, The Journal …, 2017 - ashpublications.org
Marginal zone lymphoma (MZL) is a heterogeneous B-cell malignancy for which no
standard treatment exists. MZL is frequently linked to chronic infection, which may induce B …
standard treatment exists. MZL is frequently linked to chronic infection, which may induce B …
Non-Hodgkin lymphoma: diagnosis and treatment
SM Ansell - Mayo Clinic Proceedings, 2015 - Elsevier
Non-Hodgkin lymphomas are lymphoid malignant neoplasms with diverse biological and
clinical behavior. Patients typically present with persistent painless lymphadenopathy, but …
clinical behavior. Patients typically present with persistent painless lymphadenopathy, but …
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
A Ruskoné-Fourmestraux, W Fischbach, BMP Aleman… - Gut, 2011 - gut.bmj.com
This consensus report of the EGILS (European Gastro-Intestinal Lymphoma Study) group
includes recommendations on the management of gastric extranodal marginal zone B-cell …
includes recommendations on the management of gastric extranodal marginal zone B-cell …
Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: improved event-free and progression-free survival with rituximab plus …
E Zucca, A Conconi, G Martinelli… - Journal of Clinical …, 2017 - journals.lww.com
Purpose There is no consensus on the optimal systemic treatment of patients with
extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. The IELSG-19 …
extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. The IELSG-19 …
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard …
M Ghielmini, SFH Schmitz, SB Cogliatti, G Pichert… - Blood, 2004 - ashpublications.org
The potential benefits of extended rituximab treatment have been investigated in a
randomized trial comparing the standard schedule with prolonged treatment in 202 patients …
randomized trial comparing the standard schedule with prolonged treatment in 202 patients …
Rituximab treatment in patients with primary Sjögren's syndrome: an open‐label phase II study
J Pijpe, GW Van Imhoff, FKL Spijkervet… - Arthritis & …, 2005 - Wiley Online Library
Methods. Fifteen patients with primary SS were included in this phase II trial. Inclusion
criteria for the early primary SS group were B cell hyperactivity (IgG> 15 gm/liter), presence …
criteria for the early primary SS group were B cell hyperactivity (IgG> 15 gm/liter), presence …
Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis …
E Zucca, A Conconi, D Laszlo… - Journal of Clinical …, 2013 - ascopubs.org
Purpose Apart from localized gastric disease, there is no consensus on standard initial
treatment of mucosa-associated lymphoid tissue lymphoma. The IELSG-19 study …
treatment of mucosa-associated lymphoid tissue lymphoma. The IELSG-19 study …